ClinicalTrials.gg
Status unknownNCT00360321Updated Jun 25, 2026

Descriptive Study of a French Sample of "at Risk" and Pathological Gamblers Followed in a French Structure Specialised in Addictive Disorders.

An observational study in Pathological Gambling, sponsored by Nantes University Hospital. Status unknown at 1 site in France. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by Nantes University Hospital · Observational

The sponsor has not verified this record recently (last verified Jul 2006), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Time perspective
Prospective
Sex
All
01

Study summary

International surveys about pathological gambling estimate that there are about 1 to 3 per cent of gamblers who develop a pathological behavior about gamble.In France, pathological gambling is not a priority of public health, in contrast with other addictive disorders, like alcoholism or nicotine addiction. The aim of our study is to describe accurately for the first time in France, a sample of "at risk" and pathological French gamblers. We want to collect socio-demographical and clinical data from this subjects (story of the addictive behaviour, co morbidities, and more specifically, detailed study of pathological gamblers' personality), in order to compare our data with those of international literature.Secondarily, we want to test the feasibility of this kind of detailed evaluations for another study planned for 2007-2008 and which purpose will be to compare pathological gamblers' personality characteristics according to the kind of game that they mainly practice.The participation at the study will be proposed to every patient consulting in the "service d'addictologie du CHU de Nantes". The study consists in a single evaluation (about 8 hours) with standardized tools used all other the world.

02

Conditions studied

  • Pathological Gambling

Browse trials for

03

In context

Gambling

158 studies on the registry are indexed under Gambling; 42 are open to participants now.

Browse Gambling studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 839 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 70
  • Consulting or ex-consulting since 2000 in the "service d'addictologie du CHU de Nantes"
  • Who meet sufficient criteria of pathological or "at risk" gambling in the section about pathological gambling
  • Who accept to participate
  • Who give their consent
  • Who don't have any exclusion criteria

Exclusion criteria

Exclusion Criteria:

  • Gambling behaviour directly and chronologically explain by an acute maniac fit
  • Superior function trouble
  • Who don't agree to participate
  • Difficulties in reading or writing in French
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Time perspective
Prospective
06

Study locations

1 site
  • CHU de Nantes
    Nantes, 44093, France
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00360321
Responsible party
Sponsor
First posted
Aug 4, 2006
Last update
Jun 25, 2026

Study contacts

VENISSE Jean-Luc, Professor
Contact
jeanluc.venisse@chu-nantes.fr
00 33 2.40.20.66.40
Venisse Jean Luc, Professor
principal investigator · Nantes University Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion